University Hospitals Dorset NHS Foundation Trust

The University Hospitals Dorset NHS Foundation Trust - Poole Hospital incorporates Poole Hospital and Royal Bournemouth General Hospital in Dorset https://www.uhd.nhs.uk/

In 2020, Poole Hospital NHS Foundation Trust and Royal Bournemouth General Hospital merged into University Hospitals Dorset NHS Foundation Trust.

View previous outcomes for Poole

View previous outcomes for Bournemouth

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
  • Support service facilities:
    • Availability of 24 hour palliative care advice

Data Quality
All Patients: Trust Network National
Number of patients in Audit 430 1833 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 90 91 86
– Performance status (%) 59 75 89
Patients having major resection: Trust Network National
Number of patients in Audit 218 1075 19631
ASA grade 1 (%) 3 4 9
ASA grade 2 (%) 36 56 53
ASA grade 3 (%) 22 28 31
ASA grade 4+ (%) 1 2 2
ASA grade not recorded (%) 38 11 4
Data completeness of:
7 Audit items for risk-adjustment (%) 15 78 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 430 1833 35779
Seen by Clinical Nurse Specialist (%) 99 76 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 218 1075 19614
Distant metastases (%) 3 5 5
Urgent or emergency surgery (%) 10 10 15
At least 12 lymph nodes excised (%) 19 75 84
Laparoscopic surgery attempted (%) 56 75 72
Risk-adjusted length of stay > 5 days (%) N/A 51 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 63 N/A 10747
Adjuvant chemotherapy (%) 56 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 32 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 29 N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 37 N/A 4251
Neoadjuvant therapy (%) 26 N/A 33
Circumferential resection margin: Recorded (%) 5 79 89
Circumferential resection margin: Negative (%) 5 74 83
Rectal volume 35 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 165 978 19644
APER/Hartmanns (%) 38 26 37

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd